![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Phalanx Labs Private Limited Hyderabad In, based in India, is a pharmaceutical company.
One of their significant offerings is Tadalafil, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2015-049 - Rev 01
This Chemical Type CEP, issued on May 07, 2019, remains in force until March 17, 2021, ensuring its reliability within the pharmaceutical industry.
Substance Number 2606 associated with this CEP further emphasizes